1
|
Cui H, Lin D, Qun D, Bai X. Kinetically Controlled Stereoselective Synthesis of 2-Oxo-2-aryl-1,3,2-dioxaphosphorinane Derivatives via a Palladium-Catalyzed Reaction. J Org Chem 2024; 89:2858-2872. [PMID: 38356243 DOI: 10.1021/acs.joc.3c02151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2024]
Abstract
Chiral phosphonate esters have been widely applied in the fields of organic chemistry, medicine, and photoelectric materials. However, it requires the challenging enantioselective synthesis of cyclic phosphonate esters with the desired chiral configuration. The two epimers of 2-oxo-2H-1,3,2-dioxaphosphorinane derivatives should have different reactivities in Pd-catalyzed coupling reactions, which could lead to an effective methodology for the asymmetric synthesis of 2-oxo-2-aryl-1,3,2-dioxaphosphorinane derivatives. A thorough investigation of the coupling reactions both computationally and experimentally led to the stereoselective synthesis of chiral cyclic phosphonate esters. The axial isomer of products can be obtained with both high diastereoselectivity and good chemical yields from the mixture of 2-oxo-2H-1,3,2-dioxaphosphorinane derivatives under kinetically controlled conditions.
Collapse
Affiliation(s)
- Hongming Cui
- The Center for Combinatorial Chemistry and Drug Discovery, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, P. R. China
| | - Daizong Lin
- Changchun Discovery Sciences, Ltd., Changchun, Jilin 130021, P. R. China
| | - Dang Qun
- The Center for Combinatorial Chemistry and Drug Discovery, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, P. R. China
| | - Xu Bai
- The Center for Combinatorial Chemistry and Drug Discovery, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, P. R. China
- Beryl Therapeutics, Inc., Suite 4, Building 19, 2036 West Wengjiao Rd., Haicang District, Xiamen, Fujian 361026, P. R. China
| |
Collapse
|
2
|
Yadav S, Bharti S, Mathur P. GlucoKinaseDB: A comprehensive, curated resource of glucokinase modulators for clinical and molecular research. Comput Biol Chem 2023; 103:107818. [PMID: 36680885 DOI: 10.1016/j.compbiolchem.2023.107818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Revised: 01/10/2023] [Accepted: 01/12/2023] [Indexed: 01/19/2023]
Abstract
Glucokinase (GK), an isoform of hexokinase expressed predominantly in liver, pancreas and hypothalamus is crucial to blood glucose management. It is a critical component of the glucose-sensing mechanism of the pancreatic islet cells and glycogen regulation in hepatocytes. GK modulators such as allosteric GKAs (glucokinase activators) and GK-GKRP (glucokinase regulatory protein) disruptors have found potential applications as safer antihyperglycemics. Recent studies have also demonstrated the potential of GK modulators as antiparasitic agents. Researchers targeting GK often undertake the time-consuming task of independently collecting and compiling modulator information due to the lack of any dedicated single-platform resource. Towards this, in the present study we demonstrate the design and development of GlucoKinaseDB (GKDB), a comprehensive, curated, online resource of GK modulators. GKDB contains experimentally derived structural and bioactivity information of 1723 modulators along with their detailed molecular descriptors. The web-interface is user-friendly with features such as in-browser visualization, advanced search queries, cross-links to other databases and original reference etc. The bioactivity and descriptor data can be downloaded in bulk (for entire database) or for individual modulators. The 3D structures are also downloadable in multiple formats. GKDB employs a PHP-based web design with Bootstrap styling and a MySQL database backend. GKDB can be utilized for clinical and molecular research via development of pharmacophore hypotheses, QSAR/QSPR models, predictive machine learning models etc. GKDB is freely accessible online at https://glucokinasedb.in.
Collapse
Affiliation(s)
- Siddharth Yadav
- Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India
| | - Samuel Bharti
- Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India
| | - Puniti Mathur
- Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India.
| |
Collapse
|
3
|
Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators. J Diabetes Metab Disord 2022; 21:1129-1137. [PMID: 35673438 PMCID: PMC9167346 DOI: 10.1007/s40200-022-01019-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2021] [Accepted: 02/28/2022] [Indexed: 10/18/2022]
Abstract
Diabetes mellitus is a worldwide impacting disorder and the ratio through which the number of diabetic patients had increased worldwide, puts medical professionals to serious stress for its effective management. Due to its polygenic origin and involvement of multiple genes to its pathophysiology, leads to understanding of this ailment more complex. It seems that current interventions, such as dietary changes, life style changes and drug therapy such as oral hypoglycaemics and insulin, are unable to halt the trend. There are various novel and emerging targets on which the researchers are paying attention to combat with this ailment successfully. Human glucokinase (GK) enzyme is one of these novel and emerging targets for management of diabetes. Its availability in the pancreas and liver cells makes this target more lucrative. GK's presence in the pancreatic and hepatic cells plays a very important function for the management of glucose homoeostasis. Small molecules that activate GK allosterically provide an alternative strategy for restoring/improving glycaemic regulation, especially in type 2 diabetic patients. Although after enduring many setbacks in the development of the GK activators, interest has been renewed especially due to introduction of novel dual acting GK activator dorzagliatin, and a novel hepato-selective GK activator, TTP399. This review article has been formulated to discuss importance of GK in glucose homeostasis, recent updates on small molecules of GK activators, clinical status of GK activators and challenges in development of GK activators.
Collapse
|
4
|
Rajput S, Kaur R, Jain N. Pd and photoredox dual catalysis assisted decarboxylative ortho-benzoylation of N-phenyl-7-azaindoles. Org Biomol Chem 2022; 20:1453-1461. [DOI: 10.1039/d1ob02338a] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Directing group assisted decarboxylative ortho-benzoylation of N-aryl-7-azaindoles with α-keto acids has been achieved by synergistic visible light promoted photoredox and palladium catalysis. The approach tenders rapid entry to aryl ketone...
Collapse
|
5
|
Thilagavathi R, Hosseini-Zare MS, Malini M, Selvam C. A comprehensive review on glucokinase activators: Promising agents for the treatment of Type 2 diabetes. Chem Biol Drug Des 2021; 99:247-263. [PMID: 34714587 DOI: 10.1111/cbdd.13979] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2021] [Revised: 10/10/2021] [Accepted: 10/23/2021] [Indexed: 01/07/2023]
Abstract
Glucokinase is a key enzyme which converts glucose into glucose-6-phosphate in the liver and pancreatic cells of the human. In the liver, glucokinase promotes the synthesis of glycogen, and in the pancreas, it helps in glucose-sensitive insulin release. It serves as a "glucose sensor" and thereby plays an important role in the regulation of glucose homeostasis. Due to this activity, glucokinase is considered as an attractive drug target for type 2 diabetes. It created a lot of interest among the researchers, and several small molecules were discovered. The research work was initiated in 1990. However, the hypoglycemic effect, increased liver burden, and loss of efficacy over time were faced during clinical development. Dorzagliatin, a novel glucokinase activator that acts on both the liver and pancreas, is in the late-stage clinical development. TTP399, a promising hepatoselective GK activator, showed a clinically significant and sustained reduction in glycated hemoglobin with a low risk of adverse effects. The successful findings generated immense interest to continue further research in finding small molecule GK activators for the treatment of type 2 diabetes. The article covers different series of GK activators reported over the past decade and the structural insights into the GK-GK activator binding which, we believe will stimulate the discovery of novel GK activators to treat type 2 diabetes.
Collapse
Affiliation(s)
- Ramasamy Thilagavathi
- Department of Biotechnology, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore, India
| | - Maryam Sadat Hosseini-Zare
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA
| | - Manokaran Malini
- Department of Biotechnology, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore, India
| | - Chelliah Selvam
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA
| |
Collapse
|
6
|
Yu JT, Shan Y, Yuan C, Pan C. Iridium-catalyzed selective ortho C H carbenoid functionalization of N-aryl-7-azaindoles with diazotized Meldrum’s acid. Tetrahedron Lett 2021. [DOI: 10.1016/j.tetlet.2020.152703] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Grewal AS, Lather V, Charaya N, Sharma N, Singh S, Kairys V. Recent Developments in Medicinal Chemistry of Allosteric Activators of Human Glucokinase for Type 2 Diabetes Mellitus Therapeutics. Curr Pharm Des 2020; 26:2510-2552. [PMID: 32286938 DOI: 10.2174/1381612826666200414163148] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2019] [Accepted: 04/07/2020] [Indexed: 12/11/2022]
Abstract
BACKGROUND Glucokinase (GK), a cytoplasmic enzyme catalyzes the metabolism of glucose to glucose- 6-phosphate with the help of ATP and aids in the controlling of blood glucose levels within the normal range in humans. In pancreatic β-cells, it plays a chief role by controlling the glucose-stimulated secretion of insulin and in liver hepatocyte cells, it controls the metabolism of carbohydrates. GK acts as a promising drug target for the pharmacological treatment of patients with type 2 diabetes mellitus (T2DM) as it plays an important role in the control of carbohydrate metabolism. METHODS Data used for this review was based on the search from several science databases as well as various patent databases. The main data search terms used were allosteric GK activators, diabetes mellitus, type 2 diabetes, glucokinase, glucokinase activators and human glucokinase. RESULTS This article discusses an overview of T2DM, the biology of GK, the role of GK in T2DM, recent updates in the development of small molecule GK activators reported in recent literature, mechanism of action of GK activators and their clinical status. CONCLUSION GK activators are the novel class of pharmacological agents that enhance the catalytic activity of GK enzyme and display their antihyperglycemic effects. Broad diversity of chemical entities including benzamide analogues, carboxamides, acrylamides, benzimidazoles, quinazolines, thiazoles, pyrimidines, pyridines, orotic acid amides, amino acid derivatives, amino phosphates and urea derivatives have been synthesized in past two decades as potent allosteric activators of GK. Presently, the pharmaceutical companies and researchers are focusing on the design and development of liver-selective GK activators for preventing the possible adverse effects associated with GK activators for the long-term treatment of T2DM.
Collapse
Affiliation(s)
- Ajmer S Grewal
- Chitkara College of Pharmacy, Chitkara University, Punjab, India
| | - Viney Lather
- Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India
| | - Neha Charaya
- Jan Nayak Ch. Devi Lal Memorial College of Pharmacy, Haryana, India
| | - Neelam Sharma
- Chitkara College of Pharmacy, Chitkara University, Punjab, India
| | - Sukhbir Singh
- Chitkara College of Pharmacy, Chitkara University, Punjab, India
| | - Visvaldas Kairys
- Department of Bioinformatics, Institute of Biotechnology, Vilnius University, Vilnius, Lithuania
| |
Collapse
|
8
|
Tian Y, Kong XQ, Niu J, Huang YB, Wu ZH, Xu B. Rhodium-catalyzed regioselective C(sp2)–H bond activation reactions of N-(hetero)aryl-7-azaindoles and cross-coupling with α-carbonyl sulfoxonium ylides. Tetrahedron Lett 2020. [DOI: 10.1016/j.tetlet.2020.151627] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
9
|
BAG RAGHUNATH, SARKAR TANUMAY, KUMAR SUNDARAVELVIVEK, TALUKDAR KANGKAN, PUNNIYAMURTHY THARMALINGAM. BINOL accelerated Ru(II)-catalyzed regioselective C-H functionalization of arenes with disulfides and diselenides. J CHEM SCI 2019. [DOI: 10.1007/s12039-019-1709-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
10
|
Carrër A, Turban S, Provost N, Caliez A, Lamarche G, Zanirato G, Beucher M, Pean C, Mirguet O, Perron-Sierra F, Michelet V. Juniperanol: First total synthesis and evaluation in Type 2 Diabetes disease. Bioorg Chem 2019; 92:103243. [PMID: 31518756 DOI: 10.1016/j.bioorg.2019.103243] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2019] [Revised: 08/31/2019] [Accepted: 08/31/2019] [Indexed: 01/19/2023]
Abstract
The first total synthesis of juniperanol, the tricyclic sesquiterpenoid enantiomer of α-cedrol is described. The synthesis relies on stereoselective gold-catalyzed Ohloff-type propargylic ester rearrangement performed on a 10 g scale, and a carbocationic cascade in the presence of acetyl methanesulfonate. The ability of juniperanol to interfere in glucose processes in different cell types is described.
Collapse
Affiliation(s)
- A Carrër
- PSL Research University, Chimie ParisTech-CNRS, Institut de Recherche de Chimie Paris, 11 rue P. et M. Curie, 75005 Paris, France
| | - S Turban
- Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-Seine, France
| | - N Provost
- Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-Seine, France
| | - A Caliez
- Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-Seine, France
| | - G Lamarche
- Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-Seine, France
| | - G Zanirato
- Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-Seine, France
| | - M Beucher
- Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-Seine, France
| | - C Pean
- Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-Seine, France
| | - O Mirguet
- Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-Seine, France
| | - F Perron-Sierra
- Institut de Recherches Servier, 125 Chemin de Ronde, 78290 Croissy-Seine, France
| | - V Michelet
- PSL Research University, Chimie ParisTech-CNRS, Institut de Recherche de Chimie Paris, 11 rue P. et M. Curie, 75005 Paris, France; University Côte d'Azur, Institut de Chimie de Nice, Parc Valrose, Faculté des Sciences, 06100 Nice, France
| |
Collapse
|
11
|
Kaushik A, Kaushik M. Recent Updates on Glucokinase Activators and Glucokinase Regulatory Protein Disrupters for the Treatment of Type 2 Diabetes Mellitus. Curr Diabetes Rev 2019; 15:205-212. [PMID: 30039763 DOI: 10.2174/1573399814666180724100749] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/28/2017] [Revised: 07/09/2018] [Accepted: 07/16/2018] [Indexed: 01/05/2023]
Abstract
INTRODUCTION The impairment of glucose metabolism leads to hyperglycemia and type-2 diabetes mellitus. Glucokinase enzyme is the key regulator of glucose homeostasis that catalyzes the conversion of glucose to glucose-6-phosphate in liver and pancreatic cells. In hepatocytes, GK controls the glucose uptake and glycogen synthesis. The action of liver GK is controlled by Glucokinase Regulatory Protein (GKRP) partially. In fasting conditions the GKRP binds with GK and inactivate it from carbohydrate metabolism and serve as new target for treatment of diabetes mellitus. However, the GK activators as potential antidiabetic agents but results in increased risks of hypoglycemia. CONCLUSION The allosteric inhibitors of the GK-GKRP interaction are coming as alternative agents that can mitigate the risk associated with GK activators. This review discusses the recent advances and current status of potential molecules targeted to GK activators and GK-GKRP disrupters.
Collapse
Affiliation(s)
- Aditi Kaushik
- I.K.Gujral Punjab Technical University, Jalandhar - Kapurthala Highway, Kapurthala, Punjab, India
| | | |
Collapse
|
12
|
Vats TK, Mishra A, Deb I. Rhodium-Catalyzed Direct and Selective ortho
C−H Chalcogenation of N
-(Hetero)aryl-7-azaindoles. Adv Synth Catal 2018. [DOI: 10.1002/adsc.201800090] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Tripta Kumari Vats
- Organic & Medicinal Chemistry Division; CSIR-Indian Institute of Chemical Biology; 4-Raja S. C. Mullick Road Jadavpur, Kolkata 700032 India
| | - Aniket Mishra
- Organic & Medicinal Chemistry Division; CSIR-Indian Institute of Chemical Biology; 4-Raja S. C. Mullick Road Jadavpur, Kolkata 700032 India
| | - Indubhusan Deb
- Organic & Medicinal Chemistry Division; CSIR-Indian Institute of Chemical Biology; 4-Raja S. C. Mullick Road Jadavpur, Kolkata 700032 India
| |
Collapse
|
13
|
Mishra A, Vats TK, Nair MP, Das A, Deb I. Rhodium-Catalyzed sp2 C–H Acetoxylation of N-Aryl Azaindoles/N-Heteroaryl Indolines. J Org Chem 2017; 82:12406-12415. [DOI: 10.1021/acs.joc.7b02203] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Aniket Mishra
- Organic and Medicinal Chemistry
Division, Indian Institute of Chemical Biology, 4-Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India
| | - Tripta Kumari Vats
- Organic and Medicinal Chemistry
Division, Indian Institute of Chemical Biology, 4-Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India
| | - Mahesh P. Nair
- Organic and Medicinal Chemistry
Division, Indian Institute of Chemical Biology, 4-Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India
| | - Arindam Das
- Organic and Medicinal Chemistry
Division, Indian Institute of Chemical Biology, 4-Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India
| | - Indubhusan Deb
- Organic and Medicinal Chemistry
Division, Indian Institute of Chemical Biology, 4-Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India
| |
Collapse
|
14
|
Morzyk-Ociepa B, Szmigiel K, Petrus R, Turowska-Tyrk I, Danuta Michalska. A novel coordination polymer of 7-azaindole-3-carboxylic acid with sodium ions: crystal and molecular structures, vibrational spectra and DFT calculations. J Mol Struct 2017. [DOI: 10.1016/j.molstruc.2017.05.059] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
15
|
Wang Z, Shi X, Zhang H, Yu L, Cheng Y, Zhang H, Zhang H, Zhou J, Chen J, Shen X, Duan W. Discovery of cycloalkyl-fused N-thiazol-2-yl-benzamides as tissue non-specific glucokinase activators: Design, synthesis, and biological evaluation. Eur J Med Chem 2017; 139:128-152. [PMID: 28800453 DOI: 10.1016/j.ejmech.2017.07.051] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2017] [Revised: 06/07/2017] [Accepted: 07/22/2017] [Indexed: 11/18/2022]
Abstract
Glucokinase (GK) activators are being developed for the treatment of type 2 diabetes mellitus (T2DM). However, existing GK activators have risks of hypoglycemia caused by over-activation of GK in islet cells and dyslipidemia caused by over-activation of intrahepatic GK. In the effort to mitigate risks of hypoglycemia and dyslipidemia while maintaining the promising efficacy of GK activator, we investigated a series of cycloalkyl-fused N-thiazol-2-yl-benzamides as tissue non-specific partial GK activators, which led to the identification of compound 72 that showed a good balance between in vitro potency and enzyme kinetic parameters, and protected β-cells from streptozotocin-induced apoptosis. Chronic treatment of compound 72 demonstrated its potent activity in regulation of glucose homeostasis and low risk of dyslipidemia with diabetic db/db mice in oral glucose tolerance test (OGTT). Moreover, acute treatment of compound 72 did not induce hypoglycemia in C57BL/6J mice even at 200 mg/kg via oral administration.
Collapse
Affiliation(s)
- Zhengyu Wang
- Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing 210009, PR China
| | - Xiaofan Shi
- CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China
| | - Huan Zhang
- Center of Drug Discovery, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing, Jiangsu 210009, PR China
| | - Liang Yu
- CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, PR China
| | - Yanhua Cheng
- Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing 210009, PR China
| | - Hefeng Zhang
- University of Chinese Academy of Sciences, Beijing 100049, PR China; Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, PR China
| | - Huibin Zhang
- Center of Drug Discovery, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing, Jiangsu 210009, PR China
| | - Jinpei Zhou
- Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing 210009, PR China.
| | - Jing Chen
- CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, PR China.
| | - Xu Shen
- CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, PR China
| | - Wenhu Duan
- Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, PR China.
| |
Collapse
|
16
|
Mari G, Crescentini LD, Favi G, Lombardi P, Fiorillo G, Giorgi G, Mantellini F. Heteroring-Annulated Pyrrolino-Tetrahydroberberine Analogues. ASIAN J ORG CHEM 2017. [DOI: 10.1002/ajoc.201700051] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Affiliation(s)
- Giacomo Mari
- Biomolecular Science Department; Organic Chemistry and Organic Natural Compounds Section; University of Urbino “Carlo Bo”; Via I Maggetti 24 61029 Urbino (PU) Italy
| | - Lucia De Crescentini
- Biomolecular Science Department; Organic Chemistry and Organic Natural Compounds Section; University of Urbino “Carlo Bo”; Via I Maggetti 24 61029 Urbino (PU) Italy
| | - Gianfranco Favi
- Biomolecular Science Department; Organic Chemistry and Organic Natural Compounds Section; University of Urbino “Carlo Bo”; Via I Maggetti 24 61029 Urbino (PU) Italy
| | - Paolo Lombardi
- Naxospharma; Via Giuseppe Di Vittorio 70 20026 Novate Milanese (MI) Italy
| | - Gaetano Fiorillo
- Naxospharma; Via Giuseppe Di Vittorio 70 20026 Novate Milanese (MI) Italy
| | - Gianluca Giorgi
- Department of Chemistry; University of Siena; Via Aldo Moro 53100 Siena Italy
| | - Fabio Mantellini
- Biomolecular Science Department; Organic Chemistry and Organic Natural Compounds Section; University of Urbino “Carlo Bo”; Via I Maggetti 24 61029 Urbino (PU) Italy
| |
Collapse
|
17
|
General methods for the synthesis and late-stage diversification of 2,4-substituted 7-azaindoles. Tetrahedron Lett 2016. [DOI: 10.1016/j.tetlet.2016.09.029] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
|
18
|
Mishra A, Vats TK, Deb I. Ruthenium-Catalyzed Direct and Selective C–H Cyanation of N-(Hetero)aryl-7-azaindoles. J Org Chem 2016; 81:6525-34. [DOI: 10.1021/acs.joc.6b01148] [Citation(s) in RCA: 53] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Aniket Mishra
- Organic and Medicinal Chemistry
Division, Indian Institute of Chemical Biology, 4-Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India
| | - Tripta Kumari Vats
- Organic and Medicinal Chemistry
Division, Indian Institute of Chemical Biology, 4-Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India
| | - Indubhusan Deb
- Organic and Medicinal Chemistry
Division, Indian Institute of Chemical Biology, 4-Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India
| |
Collapse
|
19
|
Liu B, Li R, Zhan W, Wang X, Ge Z, Li R. Rh(iii)-catalyzed C–H oxidative ortho-olefination of arenes using 7-azaindole as a directing group and utilization in the construction of new tetracyclic heterocycles containing a 7-azaindole skeleton. RSC Adv 2016. [DOI: 10.1039/c6ra07478b] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
A wide range of Rh(iii)-catalyzed ortho-olefinated 7-azaindole derivatives as well as novel tetracyclic heterorings were achieved, which could served as useful starting materials for the construction of biological molecules.
Collapse
Affiliation(s)
- Bin Liu
- State Key Laboratory of Natural and Biomimetic Drugs
- Peking University
- Beijing 100191
- China
| | - Ridong Li
- State Key Laboratory of Natural and Biomimetic Drugs
- Peking University
- Beijing 100191
- China
| | - Wei Zhan
- State Key Laboratory of Natural and Biomimetic Drugs
- Peking University
- Beijing 100191
- China
| | - Xin Wang
- State Key Laboratory of Natural and Biomimetic Drugs
- Peking University
- Beijing 100191
- China
| | - Zemei Ge
- State Key Laboratory of Natural and Biomimetic Drugs
- Peking University
- Beijing 100191
- China
| | - Runtao Li
- State Key Laboratory of Natural and Biomimetic Drugs
- Peking University
- Beijing 100191
- China
| |
Collapse
|